We validate these findings in transgenic mice and observe that the pituitary adenomas of X-LAG patients, that are characterized by high expression levels of GPR1017, have an increase of PKC activity compared to other GH-secreting tumors. This evidence concerns the gene PRRT2 and pituitary gland adenoma.